Northwell Health Ventures co-led Conversa’s Series B funding round alongside Builders VC in June 2020. The New Hyde Park, N.Y.-based health system deployed Conversa’s platform last year to help with its COVID-19 response. Conversa’s platform offers automated chatbots to engage, monitor and manage patients for care conditions and services including COVID-19, chronic care, acute discharge, perioperative and oncology.
Other investors in Conversa include UH Ventures — the venture arm of Cleveland-based University Hospitals — P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health and Nassau Street Ventures, according to the release.
Conversa will use the additional $8 million to scale its tech platform and expand its automated virtual care digital tools. To date, the company has raised $34 million.
Editor’s note: This article was updated at 1 p.m. CST on Jan. 20.
More articles on digital transformation:
Harvard, MIT and Boston-area hospitals get $76M for health innovation center
Mayo Clinic, Microsoft, Epic and more join forces to improve digital COVID-19 vaccination records
CVS Health launches voice-powered home care monitoring platform: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
